Search Results - "Jan, Bruger"
-
1
Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay
Published in Frontiers in immunology (20-05-2021)“…Adaptive immune responses to structural proteins of the virion play a crucial role in protection against coronavirus disease 2019 (COVID-19). We therefore…”
Get full text
Journal Article -
2
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich
Published in International journal of environmental research and public health (30-03-2021)“…Given the large number of mild or asymptomatic SARS-CoV-2 cases, only population-based studies can provide reliable estimates of the magnitude of the pandemic…”
Get full text
Journal Article -
3
The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 – Results from a prospective cohort of outpatient COVID-19 cases
Published in Virology (New York, N.Y.) (01-04-2022)“…Risk factors for disease progression and severity of SARS-CoV-2 infections require an understanding of acute and long-term virological and immunological…”
Get full text
Journal Article -
4
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany)
Published in BMC infectious diseases (08-09-2021)“…Abstract Background In the 2nd year of the COVID-19 pandemic, knowledge about the dynamics of the infection in the general population is still limited. Such…”
Get full text
Journal Article -
5
In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients
Published in Infectious diseases and therapy (01-09-2021)“…Background Quantitative serological assays detecting response to SARS-CoV-2 are needed to quantify immunity. This study analyzed the performance and…”
Get full text
Journal Article -
6
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
Published in BMC infectious diseases (13-07-2023)“…Population-based serological studies allow to estimate prevalence of SARS-CoV-2 infections despite a substantial number of mild or asymptomatic disease…”
Get full text
Journal Article -
7
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison
Published in Virology journal (01-09-2023)“…Abstract Background Measuring specific anti-SARS-CoV-2 antibodies has become one of the main epidemiological tools to survey the ongoing SARS-CoV-2 pandemic,…”
Get full text
Journal Article -
8
From first to second wave: follow-up of the prospective COVID-19 cohort
Published in BMC infectious diseases (08-09-2021)“…In the 2nd year of the COVID-19 pandemic, knowledge about the dynamics of the infection in the general population is still limited. Such information is…”
Get full text
Journal Article -
9
A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system
Published in Microbiology spectrum (02-04-2024)“…SARS-CoV-2 spreads pandemically since 2020; in 2021, effective vaccinations became available and vaccination campaigns commenced. Still, it is hard to track…”
Get full text
Journal Article